Breaking News

Amgen Breaks Ground for New NC Biomanufacturing Facility

The facility will use new technologies that maximize efficiency and help ensure the ability to produce a broad range of medicines.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen broke ground at its newest biomanufacturing facility in Holly Springs, NC. The facility, expected to be operational by 2025, will support Amgen’s medicines that treat illnesses such as cancer and heart disease.   “Amgen is adding to North Carolina’s strong economic growth with the addition of its newest manufacturing plant to our already robust biomanufacturing ecosystem,” said Roy Cooper, Governor of North Carolina. “We welcome Amgen’s choice to b...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters